Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Benefits Of Grapefruit

UCLA Study Discovers Enzyme That Controls 'Bad' Cholesterol
BACKGROUND: Low-density lipoprotein (LDL) is the so-called "bad cholesterol" often linked to medical problems like heart disease and clogged arteries. Cells in the liver produce a specific receptor that sticks to LDL and removes it from the blood, lowering cholesterol levels. Statin drugs also reduce LDL cholesterol levels by boosting cells" production of the receptor.
generic viagra online
Signs Of Heart Damage Evident In Overweight Male Teens With Normal Blood Pressures
Even while their blood pressures are still normal, overweight male teens may have elevated levels of a hormone known to increase pressures as well as early signs of heart damage, researchers say.
News of the day
Boxers Holyfield, Retta To Participate In HIV/AIDS Charity Fight In Ethiopia
Boxer Evander Holyfield will fight Sammy Retta on July 26 in Ethiopia in an effort to raise money for HIV/AIDS organizations, Reuters India reports. Event organizers hope to raise between $5 million and $10 million from the fight. "I continue to strive to be the very best, but what got me to come here is" HIV/AIDS, Holyfield said, adding, "If we don"t find a cure to this, we"ll be extinct." According to Everton Boland -- CEO of Golden Globe, which is promoting the fight -- a significant portion of money raised will go directly to organizations addressing HIV/AIDS. Organizers said that a group established by African first ladies is the only recipient selected to date but they are considering others (Malone, Reuters India, 5/20).
Sexual Health

Metabolic Disease Drug Discovery Conference: Monday September 21, 2009

on both Clinical and Business Fronts 3:00 Shaping Business Development Through Collaboration Ventures -- Identifying what are the requirements to establish early stage research collaborations -- Extending knowledge gathering beyond existing in-house capabilities -- Expanding the value of a partnership beyond a single deal -- Outsourcing lead finding and early development to partnering companies Dr. Dennis Kim, SVP, Metabolic Diseases, Orexigen Therapeutics Inc 3:45 Scientific Licensing Strategy & Process: Focus on Metabolic Disease Interests -- Outlining Merck"s scientific licensing strategy and review process -- Providing a review of the partnering process, including initiation and negotiation processes -- Identifying what Merck looks for in a potential therapeutic candidate -- Discussing specific licensing priorities for the metabolic diseases area Dr. Lauren Shearman, Associate Director, Scientific Liaison External Scientific Affairs, Merck 4:30 End of Conference IDGA

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009